Revenue beats, profit collapses—margin recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue beat (125 Cr vs ~70 Cr baseline). QoQ profit down 90%. Prior guidance 'stronger bottom-line'—top-line hit, bottom-line missed sharply.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue growth (80% YoY) and ₹618 Cr order backlog are structural positives, but Q1 PAT collapsed to ₹0.5 Cr (0.4% NPM) despite 80% scale—evidence of margin control breakdown. Management targets 7-8% EBITDA in '1-2 years,' but timeline is vague and near-term visibility poor. Penta and SAEL are strategic wins but unproven in profit contribution. Key risk: order realization delays (SAEL 6-8 mo, trading 1-1.5 yr) and margin recovery unsubstantiated.
₹125.3 Cr
Revenue · +80.2% YoY₹0.5 Cr
Reported PAT · +120.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Earnings quality
What changed since the last call
Order backlog quantified
Upgrade₹618 Cr backlog reported; SAEL ₹52 Cr win is new. Order inflow ₹283 Cr shows robust pipeline. Prior call did not size backlog.
Penta Automation acquired
NewStrategic automation play, ₹25 Cr baseline revenue, 25-30% growth expected over 2-3 years. Synergies claimed across divisions. Not discussed in prior call.
Profit guidance misfire
WithdrawnPrior call promised 'stronger bottom-line'—delivered Q1 shows PAT ₹0.5 Cr, down 89.6% QoQ. No formal retraction, but execution faltered.
EBITDA margin target
New7-8% EBITDA in '1-2 years' is forward guidance, but lacks specificity. Current delivered OPM 2.5% vs call's stated 4% EBITDA; large gap unreconciled.
The Q&A
Analyst Prashantkumar pressed hard on why 80% revenue growth did not translate to operating leverage—EBITDA only 4% vs NPM 0.4%, and prior-quarter baseline unknown. Management deflected to 'next 1-2 years' and blamed nascent acquisitions. CFO blamed rounding for segment discrepancies—not credible. Investors left unsatisfied on path to profitability. Tone: polite but evasive.
Penta integration — Shaishav Vora, Prudent Investments
AnsweredAutomation required across machine tools, textiles, air engineering. Penta provides robotics and automation lines. Expected 25-30% growth over 2-3 years.
Operating profit gap — Prashantkumar Uttamlal, Individual Investor
PartialCurrent 4-6% EBITDA. Target 7-8% in next 1-2 years via operational efficiency and acquisitions maturing. Nascent businesses need time.
Trading division income — Prashantkumar Uttamlal, Individual Investor
DodgedMix of two divisions. We'll share offline.
Quickmill outlook — Arpan Gandhi, A.G. Capital Investments
AnsweredDoing well with pending orders. Expanding to Gulf, Mexico, Egypt, South America. Large orders booked in Saudi Arabia.
SAEL order upside — Prashantkumar Uttamlal, Individual Investor
PartialSolar manufacturing space will grow. This order opens doors to big opportunities. Couple of big pipelines may fructify in 2-3 quarters, 100%.
Guidance
FY27 revenue +10% YoY growth (~₹138 Cr target)
Medium'Around 10% top-line growth over last year' per MD. ₹618 Cr backlog supports target, but geopolitical headwinds (Middle East, tariffs) and order lead times (1-1.5 yr) pose realization risk.
Target 7-8% EBITDA in next 1-2 years
LowVague timeline ('1-2 years'), no FY-specific target. Current delivered OPM 2.5%, call-stated EBITDA 4%. No bridge articulated; relies on Penta synergies and operational efficiency (unproven).
Capex in machine tools and solar plants (~₹180 Cr FY27 implied)
MediumMachine tool capex yielding 30% production increase (achieved). Solar plant phased; targeting revenue-neutral in 3-4 years post 3-yr finance cost. Specific annual capex not quantified for FY27.
Risks the call surfaced
Order realization delays
HighSAEL ₹52 Cr commissioning in 6-8 months; trading orders 1-1.5 years. Delays or project cancellations could derail FY27 10% growth guidance.
Margin recovery unproven
HighPAT ₹0.5 Cr (0.4% NPM) on ₹125 Cr revenue despite 80% growth. OPM 2.5% delivered vs 4% call-stated; NPM 0.4% vs implied 2%+ EBITDA. Finance/tax costs appear high. 7-8% EBITDA target in '1-2 years' lacks quantified bridge.
Geopolitical & macro headwinds
MediumMiddle East conflict, tariff escalation, supply chain disruptions cited. Raw material cost inflation (copper, steel) being partially absorbed; pass-through to customers ongoing. Margin compression if pass-through stalls.
Integration execution risk
MediumPenta (₹25 Cr baseline) and Bioconserve (one-year-old) are early-stage. 25-30% growth expected for Penta, but no breakeven or profit confirmation. Cross-divisional synergies (automation in textiles, machine tools) are theoretical, unquantified.
Competitive & pricing pressure
MediumTextile machinery has established competitors (VA Tech Wabag, Ion Exchange for ZLD systems). Batliboi's market position unclear. Trading division dependent on overseas principals' brand and reputation.
Management
Score 6/10. MD is articulate and addresses most questions directly. CFO provides segment detail but relies on 'rounding' to explain ₹2 Cr discrepancy—lacks precision. Evasive on trading commission specifics (deferred to offline follow-up). Revenue guidance beaten (80% growth). Profit guidance missed (PAT down 89.6% QoQ). Order book solid but cash conversion broken. Margin promises ('7-8% EBITDA in 1-2 years') lack timeline, quantified bridge, or track record.
1 · 6-8 months
SAEL solar pollution-control system commissioning (₹52 Cr order)
2 · 1-2 quarters
Defense/aerospace trading orders delivery (~₹102 Cr pipeline)
3 · 1-2 years
Penta synergies realized, EBITDA margin inflection to 7-8%
Key risk: order realization delays (SAEL 6-8 mo, trading 1-1.5 yr) and margin recovery unsubstantiated.
Informational and educational content only. Not investment advice.